These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 444367)

  • 1. Antipyrine induction and hepatic vitamin D hydroxylation in man [proceedings].
    Brodie MJ; Davies DS; Dollery CT; Fraser HS; Hillyard CJ; MacIntyre I; Mucklow JE; Wilmana PF
    Br J Clin Pharmacol; 1979 Apr; 7(4):417P. PubMed ID: 444367
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of antipyrine clearance and induction of antipyrine 4-hydroxylation by 3-methylcholanthrene in rats [proceedings].
    Kroos-De Haan MA; Noordhoek J
    Br J Pharmacol; 1980 Jan; 68(1):120P. PubMed ID: 7357140
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of circulating 25-hydroxyvitamin D by antipyrine.
    Wilmana PF; Brodie MJ; Mucklow JC; Fraser HS; Toverud EL; Davies DS; Dollery CT; Hillyard CJ; Macintyre I; Park BK
    Br J Clin Pharmacol; 1979 Dec; 8(6):523-8. PubMed ID: 533574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of individual dietary constituents on antipyrine clearance in Asian immigrants [proceedings].
    Mucklow JC; Caraher MT; Henderson DB; Rawlins MD
    Br J Clin Pharmacol; 1979 Apr; 7(4):416P-417P. PubMed ID: 444366
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolism of antipyrine in man].
    Pautet F; Barret R; Daudon M; Mathian B
    Pathol Biol (Paris); 1985 Sep; 33(7):777-80. PubMed ID: 3909077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["Vitamin resistant" osteomalacia due to a defect in hepatic hydroxylation of vitamin D; reversible secondary-pseudo-hypoparathyroidism due to calcium administration].
    Renier JC; Boasson M; Bernat M; Basle M
    Sem Hop; 1977 Jul 10-20; 53(25-28):1523-9. PubMed ID: 197643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enhanced drug hydroxylation in man under diphenyl-hydantoin therapy].
    Petruch F; Schüppel RV
    Arzneimittelforschung; 1974 Jul; 24(7):1023-5. PubMed ID: 4211429
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of spironolactone on antipyrine metabolism in man.
    Huffman DH; Shoeman DW; Pentikäinen P; Azarnoff DL
    Pharmacology; 1973; 10(6):338-44. PubMed ID: 4593769
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipyrine metabolism in man.
    Kellermann GH; Luyten-Kellermann M
    Life Sci; 1978 Dec; 23(25):2485-90. PubMed ID: 732536
    [No Abstract]   [Full Text] [Related]  

  • 10. Environmental effects on antipyrine half-life in man.
    Fraser HS; Mucklow JC; Bulpitt CJ; Khan C; Mould G; Dollery CT
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 2):799-808. PubMed ID: 913037
    [No Abstract]   [Full Text] [Related]  

  • 11. Antipyrine pharmacokinetics in the pregnant rat.
    Dean M; O'Donnell L; Penglis S; Stock B
    Drug Metab Dispos; 1980; 8(4):265-7. PubMed ID: 6105062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug oxidation in Asian vegetarians.
    Mucklow JC; Rawlins MD; Brodie MJ; Boobis AR; Dollery CT
    Lancet; 1980 Jul; 2(8186):151. PubMed ID: 6105323
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the metabolism of antipyrine (phenazone) in man (author's transl)].
    Zietz E; Eichelbaum M; Dengler HJ; Spiteller G
    Arzneimittelforschung; 1978; 28(2):315-9. PubMed ID: 580401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
    Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D metabolism and chronic liver disease.
    Wills MR; Savory J
    Ann Clin Lab Sci; 1984; 14(3):189-97. PubMed ID: 6329069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medroxyprogesterone acetate does not induce antipyrine clearance and only weakly increases alpha 1-acid glycoprotein in beagle dogs.
    Abramson FP; Moore CF; Hill MD
    Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):65-78. PubMed ID: 2944196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipyrine metabolism and bronchogenic carcinoma.
    Ambre J; Graeff D; Bures F; Haupt D; Deason K
    J Med; 1977; 8(1):57-70. PubMed ID: 267157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: The relationships between liver volume and the disposition of antipyrine and indocyanine green before and after phenobarbitone treatment.
    Branch RA; Halliwell M; Jackson L; Roberts CJ
    Br J Pharmacol; 1975 Oct; 55(2):263P. PubMed ID: 1201403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.